QQ客服 官方微博 反馈留言

	Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review (SCI收录)
	Su, Jiahao[1]; Cai, Meiqin[1]; Li, Wensheng[1]; Hou, Bo[2]; He, Haiyong[2]; Ling, Cong[2]; Huang, Tengchao[2]; Liu, Huijiao[2]; Guo, Ying[1]
刊名	ONCOLOGY RESEARCH
	2016
卷号	24页码:117-128
关键词	Molecularly targeted drugs Radiotherapy and temozolomide Treatment Glioblastoma (GBM) Newly diagnosed Overall survival (OS)
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2194046
专题	华南理工大学
作者单位	1.[1]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurosurg, Guangzhou 510630, Guangdong, Peoples R China 2.[2]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510630, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Su, Jiahao[1],Cai, Meiqin[1],Li, Wensheng[1],等. Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review (SCI收录)[J]. ONCOLOGY RESEARCH,2016,24:117-128.
APA	Su, Jiahao[1].,Cai, Meiqin[1].,Li, Wensheng[1].,Hou, Bo[2].,He, Haiyong[2].,...&Guo, Ying[1].(2016).Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review (SCI收录).ONCOLOGY RESEARCH,24,117-128.
MLA	Su, Jiahao[1],et al."Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review (SCI收录)".ONCOLOGY RESEARCH 24(2016):117-128.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。